当前位置: 首页 > 期刊 > 《医药产业资讯》 > 202019
编号:13831091
Caspase-1在眼科疾病中的研究进展(4)
http://www.100md.com 2020年7月5日 《中国医药导报》 202019
     [19] Ambati J,Atkinson JP,Gelfand BD. Immunology of age-related macular degeneration [J]. Nat Rev Immunol,2013,13:438-451.

    [20] Tarallo V,Hirano Y,Gelfand BD,et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88 [J]. Cell,2012, 149(4):847-859.

    [21] Doyle SL,Campbell M,Ozaki E,et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components [J]. Nat Med,2012,18(5):791-798.

    [22] Kauppinen A,Niskanen H,Suuronen T,et al. Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-implications for age-related macular degeneration(AMD) [J]. Immunol Lett,2012,147(1/2):29-33.

    [23] Cecilia OM,José Alberto CG,José NP,et al. Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology [J]. J Diabetes Res,2019,2019:8562408.

    [24] Yerramothu P,Vijay AK,Willcox MDP. Inflammasomes,the eye and anti-inflammasome therapy [J]. Eye,2018, 32(3):491-505.

    [25] Chen H,Zhang X,Liao N,et al. Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Diabetic Retinopathy [J]. Invest Ophthalmol Vis Sci,2018,59(2):978-985.

    (收稿日期:2019-12-12), http://www.100md.com(李华章 李志坚)
上一页1 2 3 4